SMAD4 and neoplasm: In conclusion, our investigations based on human tumor transcriptomes revealed that SMAD4 mutations do not preclude elevated expression of EMT-TFs and the occurrence of gene expression patterns indicative of EMT in colorectal and pancreatic tumors.